Collecting and analyzing blood and cerebrospinal fluid samples to improve Alzheimer's disease treatments

Core G: Biofluid Biomarker Core

NIH-funded research Johns Hopkins University · NIH-11114239

This study is looking for people to help by sharing blood and spinal fluid samples so researchers can find clues that might improve how we understand and treat Alzheimer's disease and related conditions, while also teaching everyone about the importance of these findings.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11114239 on NIH RePORTER

What this research studies

This research focuses on the collection, processing, and sharing of blood and cerebrospinal fluid (CSF) samples from participants at the Johns Hopkins Alzheimer’s Disease Research Center. The goal is to analyze these biofluids to identify biomarkers that could lead to better understanding and treatment of Alzheimer's disease and related dementias. Participants will contribute to a database that tracks the samples and the data derived from them, which will be used by researchers to advance knowledge in this field. Additionally, the project aims to educate both researchers and the community about the significance of these biomarkers.

Who could benefit from this research

Good fit: Ideal candidates for participation include individuals diagnosed with Alzheimer's disease or related dementias, as well as healthy volunteers for comparison.

Not a fit: Patients with conditions unrelated to Alzheimer's disease or those who are not willing to provide blood or CSF samples may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for Alzheimer's disease and related dementias.

How similar studies have performed: Previous research has shown success in using biofluid biomarkers to enhance understanding and treatment of Alzheimer's disease, indicating that this approach is promising.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.